In the last decade, undiagnosed disease programs have emerged to address the significant number of individuals with suspected but undiagnosed rare genetic diseases. In our single-center study, we have launched a pilot program for pediatric patients with undiagnosed diseases in the second-largest university hospital in the Czech Republic. This study was prospectively conducted at the Department of Pediatrics at University Hospital Brno between 2020 and 2023. A total of 58 Czech patients with undiagnosed diseases were enrolled in the study. All children underwent singleton WES with targeted phenotype-driven analysis. We identified 28 variants, including 11 pathogenic, 13 likely pathogenic, and 4 VUS according to ACMG guidelines, as diagnostic of genetic diseases in 25 patients, resulting in an overall diagnostic yield of 43%. Eleven variants were novel and had not been previously reported in any public database. The overall clinical utility (actionability) enabling at least one type of change in the medical care of the patient was 76%, whereas the average number of clinical implications to individual patient care was two. Singleton WES facilitated the diagnostic process in the Czech undiagnosed pediatric population. We believe it is an effective approach to enable appropriate counseling, surveillance, and personalized clinical management.

Center of Precision Medicine Department of Pathology University Hospital Brno Faculty of Medicine Masaryk University Brno Czech Republic

Central European Institute of Technology Masaryk University Brno Czech Republic

Centre of Molecular Biology and Genetics Department of Hematology Oncology and Internal Medicine Masaryk University and University Hospital Brno Brno Czech Republic

Department of Biology Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Medical Genetics and Genomics University Hospital Brno Faculty of Medicine Masaryk University Brno Brno Czech Republic

Department of Pediatric Anesthesiology and Intensive Care Medicine University Hospital Brno and Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pediatric Neurology University Hospital Brno Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pediatric Oncology Faculty of Medicine University Hospital Brno Masaryk University Brno Czech Republic

Department of Pediatrics University Hospital Brno Faculty of Medicine Masaryk University Cernopolni 9 613 00 Brno Czech Republic

Department of Pharmacology CZECRIN Masaryk University Faculty of Medicine Brno Czech Republic

Department of Simulation Medicine Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

Curic, E. et al. International Undiagnosed Diseases Programs (UDPs): Components and outcomes. Orphanet. J. Rare Dis.18, 348 (2023). PubMed PMC

Macnamara, E. F., D’Souza, P. & Tifft, C. J. The undiagnosed diseases program: Approach to diagnosis. Transl. Sci. Rare Dis.4, 179–188 (2019). PubMed PMC

Taruscio, D. et al. Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. Mol. Genet. Metab.116, 223 (2015). PubMed

Boycottm, K. M. et al. Care4Rare Canada: Outcomes from a decade of network science for rare disease gene discovery. Am. J. Hum. Genet.109, 1947–1959 (2022). PubMed PMC

Smedley, D. et al. 100,000 genomes pilot on rare-disease diagnosis in health care—Preliminary report. N. Engl. J. Med.20, 1868–1880 (2021). PubMed PMC

Takahashi, Y. et al. Six years’ accomplishment of the initiative on rare and undiagnosed diseases: Nationwide project in Japan to discover causes, mechanisms, and cures. J. Hum. Genet.67, 505–513 (2022). PubMed PMC

López-Martín, E., Martínez-Delgado, B., Bermejo-Sánchez, E., Alonso, J. & Posada, M. SpainUDP: The Spanish undiagnosed rare diseases program. Int. J. Environ. Res. Public. Health.15, 1746 (2018). PubMed PMC

Salvatore, M. et al. Improving diagnosis for rare diseases: The experience of the Italian undiagnosed rare diseases network. Ital. J. Pediatr.46, 130 (2020). PubMed PMC

Dillon, O. J. et al. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders. Eur. J. Hum. Genet.26, 644–651 (2018). PubMed PMC

Posey, J. E. Genome sequencing and implications for rare disorders. Orphanet J. Rare Dis.14, 153 (2019). PubMed PMC

Rosina E. et al. Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study. Molecular Genetics & Genomic Medicine. e2316 (2023). PubMed PMC

Chung, C. C. Y. et al. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet. Med.25, 100896 (2023). PubMed

Burdick, K. J. et al. Limitations of exome sequencing in detecting rare and undiagnosed diseases. Am. J. Med. Genet. A.182, 1400–1406 (2020). PubMed PMC

Kingsmore, S. F. et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in Ill infants. Am. J. Hum. Genet.105, 719–733 (2019). PubMed PMC

Adachi, T. et al. Japan’s initiative on rare and undiagnosed diseases (IRUD): Towards an end to the diagnostic odyssey. Eur. J. Hum. Genet.25, 1025–1028 (2017). PubMed PMC

Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics25, 2078–2079 (2009). PubMed PMC

McKenna, A. et al. The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res.20, 1297–1303 (2010). PubMed PMC

Lai, Z. et al. VarDict: A novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids. Res.44, e108 (2016). PubMed PMC

Kim, S. et al. Strelka2: Fast and accurate calling of germline and somatic variants. Nat. Methods.15, 591–594 (2018). PubMed

Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol.29, 24–26 (2011). PubMed PMC

Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med.17, 405–424 (2015). PubMed PMC

Miller, D. T. et al. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med.24, 1407–1414 (2022). PubMed

Gabrielaite, M. et al. A comparison of tools for copy-number variation detection in germline whole exome and whole genome sequencing data. Cancers (Basel)13, 6283 (2021). PubMed PMC

Greene, D., BioResource, N. I. H. R., Richardson, S. & Turro, E. Phenotype similarity regression for identifying the genetic determinants of rare diseases. Am. J. Hum. Genet.98, 490–499 (2016). PubMed PMC

Robinson, P. N. & Mundlos, S. The human phenotype ontology. Clin. Genet.77, 525–534 (2010). PubMed

Lee, J. Y., Oh, S. H., Keum, C., Lee, B. L. & Chung, W. Y. Clinical application of prospective whole-exome sequencing in the diagnosis of genetic disease: Experience of a regional disease center in South Korea. Ann. Hum. Genet.10.1111/ahg.12530 (2023). PubMed

Slaba, K. et al. Novel splicing variant in the PMM2 gene in a patient with PMM2-CDG syndrome presenting with pericardial effusion: A case report. Front. Genet.11, 561054 (2020). PubMed PMC

Slaba, K. et al. Two sisters with cardiac-urogenital syndrome secondary to pathogenic splicing variant in the MYRF gene with unaffected parents: A case of gonadal mosaicism?. Mol. Genet. Genomic. Med.11, e2139 (2023). PubMed PMC

Slaba, K. et al. PPP2R5D-related intellectual disability and neurodevelopmental delay—The first case in the Czech Republic. Cesk. Slov. Neurol. N.117, 205–207 (2021).

Bertoli-Avella, A. M. et al. Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort. Eur. J. Hum. Genet.29, 141–53 (2021). PubMed PMC

Wu, B. et al. Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically ill infants in the China neonatal genomes project. Crit. Care. Med.49, 1674–1683 (2021). PubMed

Clark, M. M. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. npj Genom. Med.3, 16 (2018). PubMed PMC

Manickam, K. et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet. Med.23, 2029–2037 (2021). PubMed

Whiting, P. F. et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med.155, 529–536 (2011). PubMed